C4 Therapeutics Inc
For the period ended Oct 31, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 31, 2024 · Filed Oct 31, 2024
Use the contents to explore the available documents and sections.
CCCC$3.10+5.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · RESEARCH UPDATES:
RESEARCH UPDATES:
Presented at the 7 th Annual TPD Summit Highlighting C4T’s TORPEDO® Platform: In October 2024, at the 7 th Annual TPD Summit, C4T presented kinetics-based pharmacokinetic (PK) and PD models, demonstrating the company’s ability to predict clinical PD responses across target classes.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.